|
|
City Hill Ventures, LLC is a health care focused venture capital firm whose mission is to restore human health through innovation, by building or helping other health care entrepreneurs build great companies that collectively have a transformative impact on patients, the health care industry, and society. City Hill Ventures makes primarily seed and early stage investments in private companies in life sciences (therapeutics, diagnostics, medical devices) and health care technology (information technology, wireless), with target aggregate investment in a given company ranging from approximately $100,000 to $20 million. Prior to City Hill from May 2003 to December 2010, Managing Partner, Jonathan Lim, was President, CEO, and Board Director of Halozyme Therapeutics, Inc. (NASDAQ: HALO), where he led the company's growth from 5 employees and a market value of $5 million to 140 employees and peak market capitalization of nearly $1 billion.
|
